NCT01142401 2023-11-27
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
4 trialsNCT00574236 2019-12-13
Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
University of Wisconsin, Madison
Phase 2 Terminated
NCT00025584 2013-01-23
PS-341 in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00028639 2011-07-29
PS-341 in Treating Women With Metastatic Breast Cancer
Northwestern University
Phase 2 Completed